Assembling amyloid fibrils from designed structures containing a significant amyloid beta-peptide fragment

Area of Science:

• Biochemistry
• Structural Biology
• Neuroscience

Background:

• Alzheimer's disease is characterized by amyloid plaques composed of amyloid beta-peptide (Abeta) fibrils.
• Determining the molecular structure of Abeta fibrils is crucial for developing targeted therapeutics.
• Direct structural determination of Abeta fibrils faces significant technical hurdles.

Purpose of the Study:

• To develop an alternative methodology for understanding Abeta fibril structure.
• To identify essential structural features for Abeta fibril formation using designed peptides.
• To propose a model for peptide strand alignment within amyloid fibrils.

Main Methods:

• Design of conformationally constrained decapeptide fragments of Abeta.
• Monitoring secondary structure using circular dichroism (CD) spectroscopy.
• Analyzing aggregate morphology via electron microscopy.
• Investigating residue deletions and substitutions to identify critical structural elements.

Main Results:

• Designed decapeptide variants formed fibrils morphologically identical to Abeta fibrils.
• Constrained decapeptide dimers rapidly formed intramolecular, antiparallel beta-sheets.
• Polymerization into amyloid fibrils occurred at low peptide concentrations.
• A detailed model of peptide strand alignment in fibrils was deduced.

Conclusions:

• Conformationally constrained peptides can serve as effective 'bricks' for studying amyloid fibril formation.
• The formation of an exposed beta-sheet structure may be a rate-limiting step in Abeta fibril assembly.
• This methodology provides insights into the structural basis of Alzheimer's disease pathogenesis.